Fortrea
Dipanjan Chaudhuri is an experienced professional in the pharmaceutical and clinical research sectors, currently serving as Senior Director of Client Partnerships for Patient Safety Services at Fortrea since April 2025. Dipanjan previously held the position of Vice President of Global Commercials & Strategy at 4C Pharma Solutions and led the Drug Safety Unit as Sr Director at Sitero. Prior roles include Director at Labcorp Drug Development, where responsibilities encompassed Clinical Safety and Adjudication across Pan India, and Associate Director at Bioclinica, focusing on major account management with a significant team. Dipanjan's career also includes key positions at Cognizant, Synowledge LLC, and ICON Clinical Research, along with an extensive educational background in Clinical Research from Cranfield University and MGR University.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.